A randomized, open-label, single dose, 2-treatment, 2-period, 2-way crossover study to assess the pharmacokinetic characteristics of YH14659, a fixed dose combination compared with coadministration of separate constituents under fasted condictions in healthy male subjects

Trial Profile

A randomized, open-label, single dose, 2-treatment, 2-period, 2-way crossover study to assess the pharmacokinetic characteristics of YH14659, a fixed dose combination compared with coadministration of separate constituents under fasted condictions in healthy male subjects

Recruiting
Phase of Trial: Phase I

Latest Information Update: 31 May 2017

At a glance

  • Drugs Aspirin/clopidogrel (Primary) ; Aspirin; Clopidogrel
  • Indications Coronary disorders; Embolism and thrombosis
  • Focus Pharmacokinetics
  • Sponsors Yuhan
  • Most Recent Events

    • 12 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top